169 related articles for article (PubMed ID: 30967137)
1. The CIMP-high phenotype is associated with energy metabolism alterations in colon adenocarcinoma.
Fedorova MS; Krasnov GS; Lukyanova EN; Zaretsky AR; Dmitriev AA; Melnikova NV; Moskalev AA; Kharitonov SL; Pudova EA; Guvatova ZG; Kobelyatskaya AA; Ishina IA; Slavnova EN; Lipatova AV; Chernichenko MA; Sidorov DV; Popov AY; Kiseleva MV; Kaprin AD; Snezhkina AV; Kudryavtseva AV
BMC Med Genet; 2019 Apr; 20(Suppl 1):52. PubMed ID: 30967137
[TBL] [Abstract][Full Text] [Related]
2. TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype.
Tricarico R; Madzo J; Scher G; Cohen M; Jelinek J; Maegawa S; Nagarathinam R; Scher C; Chang WC; Nicolas E; Slifker M; Zhou Y; Devarajan K; Cai KQ; Kwok T; Nakajima P; Xu J; Mancuso P; Doneddu V; Bagella L; Williams R; Balachandran S; Maskalenko N; Campbell K; Ma X; Cañadas I; Viana-Errasti J; Moreno V; Valle L; Grivennikov S; Peshkova I; Kurilenko N; Mazitova A; Koltsova E; Lee H; Walsh M; Duttweiler R; Whetstine JR; Yen TJ; Issa JP; Bellacosa A
Gastroenterology; 2023 May; 164(6):921-936.e1. PubMed ID: 36764492
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the prognostic value of CpG island methylator phenotype in rectal cancer.
Kokelaar RF; Jones H; Beynon J; Evans ME; Harris DA
Int J Colorectal Dis; 2018 Aug; 33(8):995-1000. PubMed ID: 29926233
[TBL] [Abstract][Full Text] [Related]
4. Construction of a prognostic model based on genes associated with mitochondrial energy metabolic pathway in colon adenocarcinoma and its clinical significance.
Zhang X; Liang C; Zhou B; Pang L
J Mol Recognit; 2023 Aug; 36(8):e3044. PubMed ID: 37322568
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner.
Cheng Y; Yang X; Liang L; Xin H; Dong X; Li W; Li J; Guo X; Li Y; He J; Zhang C; Wang W
BMC Cancer; 2023 Nov; 23(1):1162. PubMed ID: 38031087
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer.
Snezhkina AV; Krasnov GS; Zaretsky AR; Zhavoronkov A; Nyushko KM; Moskalev AA; Karpova IY; Afremova AI; Lipatova AV; Kochetkov DV; Fedorova MS; Volchenko NN; Sadritdinova AF; Melnikova NV; Sidorov DV; Popov AY; Kalinin DV; Kaprin AD; Alekseev BY; Dmitriev AA; Kudryavtseva AV
BMC Genomics; 2016 Dec; 17(Suppl 14):1011. PubMed ID: 28105922
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis-associated gene CISD2 suppresses colon cancer development by regulating tumor immune microenvironment.
Xu Y; Tang Q; Ding N; Zhang T; Luo H
PeerJ; 2023; 11():e15476. PubMed ID: 37304867
[TBL] [Abstract][Full Text] [Related]
8. LINC02253 promote the malignant phenotype of Colon adenocarcinoma cells by up-regulating WWP1-mediated SMAD3 ubiquitination.
Wu J; Lu X; Yu J; Li P; Yu X
Mol Cell Probes; 2023 Dec; 72():101928. PubMed ID: 37597669
[TBL] [Abstract][Full Text] [Related]
9. TRIM69: a marker of metastasis and potential sensitizer to 5-Fluorouracil and PD-1 blockers in colon adenocarcinoma.
Chi XJ; Song YB; Liu DH; Wei LQ; Zhao AR; An X; Feng ZZ; Lan XH; Lv YM; Li HJ; Lan D; He HM
BMC Gastroenterol; 2023 Aug; 23(1):292. PubMed ID: 37653392
[TBL] [Abstract][Full Text] [Related]
10. Differential roles of highly expressed PFKFB4 in colon adenocarcinoma patients.
Gu X; Dai X; Huang Y; Zhang Y; Dong L; Gao C; Wang F
Sci Rep; 2023 Sep; 13(1):16284. PubMed ID: 37770581
[TBL] [Abstract][Full Text] [Related]
11. Integrated multiplex network based approach reveled CC and CXC chemokines associated key biomarkers in colon adenocarcinoma patients.
Huang W; Hu Y; Zhang X; Xu Y; Sun Z; Ding P; Qian X; Ali A; Chen Z
Am J Cancer Res; 2023; 13(11):5531-5548. PubMed ID: 38058831
[TBL] [Abstract][Full Text] [Related]
12. Potential biomarkers: The hypomethylation of cg18949415 and cg22193385 sites in colon adenocarcinoma.
Bai H; Yan DS; Chen YL; Li QZ; Qi YC
Comput Biol Med; 2024 Feb; 169():107884. PubMed ID: 38154158
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of multiple glycolytic enzyme genes is significantly associated with disease progression and survival outcomes in prostate cancers.
Xu H; Liu W; He C; Mirza M; Li B
Am J Clin Exp Urol; 2023; 11(6):530-541. PubMed ID: 38148940
[TBL] [Abstract][Full Text] [Related]
14. A propagation-based seed-centric local community detection for multilayer environment: The case study of colon adenocarcinoma.
Pournoor E; Mousavian Z; Nowzari-Dalini A; Masoudi-Nejad A
PLoS One; 2021; 16(8):e0255718. PubMed ID: 34370784
[TBL] [Abstract][Full Text] [Related]
15. A study on metabolic characteristics and metabolic markers of gastrointestinal tumors.
Cong S; Bai S; Zhang M; Bi Y; Wang Y; Jin S; He H
Cancer Biol Ther; 2023 Dec; 24(1):2255369. PubMed ID: 37705174
[TBL] [Abstract][Full Text] [Related]
16. Proteomics analysis identified TPI1 as a novel biomarker for predicting recurrence of intrahepatic cholangiocarcinoma.
Yu WL; Yu G; Dong H; Chen K; Xie J; Yu H; Ji Y; Yang GS; Li AJ; Cong WM; Jin GZ
J Gastroenterol; 2020 Dec; 55(12):1171-1182. PubMed ID: 33089343
[TBL] [Abstract][Full Text] [Related]
17. A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis.
Liu Y; Meng F; Wang J; Liu M; Yang G; Song R; Zheng T; Liang Y; Zhang S; Yin D; Wang J; Yang H; Pan S; Sun B; Han J; Sun J; Lan Y; Wang Y; Liu X; Zhu M; Cui Y; Zhang B; Wu D; Liang S; Liu Y; Song X; Lu Z; Yang J; Li M; Liu L
Clin Cancer Res; 2019 Sep; 25(17):5407-5421. PubMed ID: 31175094
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Analysis of Primary Colon Cancer and Synchronous Solitary Liver Metastasis.
Kim EK; Song MJ; Jung Y; Lee WS; Jang HH
Cancer Genomics Proteomics; 2019; 16(6):583-592. PubMed ID: 31659112
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylated Colorectal Cancer Tumours Present a Myc-Driven Hypermetabolism with a One-Carbon Signature Associated with Worsen Prognosis.
Desterke C; Jaulin F; Dornier E
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540202
[TBL] [Abstract][Full Text] [Related]
20. Metabolism-associated molecular classification of cervical cancer.
Zhao M; Zhang X; Huan Q; Dong M
BMC Womens Health; 2023 Oct; 23(1):555. PubMed ID: 37884919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
